Clinical Trials.

What are clinical trials?

A clinical research study is a medical study that helps to answer important questions about investigational medicines, such as: Is it safe? Does it work? Are there side effects?

An investigational medicine is a treatment that is still being studied to see if it is safe and effective. Sometimes, it’s a brand-new medicine, and other times, it’s an already approved medicine being tested for a new use. Before any medicine can be prescribed by doctors, it must go through clinical research studies. These studies help determine if a treatment works and if it’s safe for patients. When you join a clinical research study, the treatment you receive is called the study medicine. Different studies test different medicines, and volunteers play a key role in helping develop new and improved treatments for the future!

Lily Trial

This study is for people who have plaque psoriasis and are overweight or have obesity. It is looking at whether using two study medications together might work better for treating both conditions. If you’re living with plaque psoriasis and struggling with weight-related challenges, this research could help explore new treatment options!

  • Plaque psoriasis is a skin condition that causes dry, scaly, and sometimes painful patches on the skin, called plaques. These plaques can be itchy, uncomfortable, or even painful, and they can range from mild to more severe.

    Beyond the skin, psoriasis can also affect your overall health. People with plaque psoriasis may be at a higher risk for other health conditions, and carrying extra weight may increase these risks even more.

  • If you have plaque psoriasis and are overweight or have obesity, you may be eligible for the TOGETHER-PsO clinical research study.

    Plaque psoriasis isn’t just a skin condition—it can also increase the risk of other health issues like heart disease and diabetes. Being overweight or having obesity can add to these risks, and people with psoriasis are more likely to experience weight-related challenges.

    This study is exploring whether using two investigational medications together may be more effective in treating both plaque psoriasis and weight concerns compared to using just one of these medications alone.

  • Yes, you may be able to join the research study if you:

    • Are 18 years of age or older

    • Have been diagnosed with moderate-to-severe plaque psoriasis for at least 6 months

    • Have obesity or overweight, with a BMI of 27 or higher

Upon calling, press Option 6 then Option 5 for the Clinical Trials Department

Aqua Trial

  • Atopic Dermatitis, also called atopic eczema, is a skin condition that causes intense itching and red, irritated patches, often on the face, arms, and legs. It’s more than just a skin issue—it can affect your overall health, mood, daily activities, and even social life.

  • The Aqua AD Trial is a clinical research study to evaluate a potential new treatment for moderate to severe Atopic Dermatitis (AD). This study aims to determine if the investigational medication, Amlitelimab, is safe and effective.

    What You Need to Know:

    • Study Treatment: Participants will receive either the study medication (Amlitelimab) or a placebo, given as an injection under the skin once every 4 weeks.

    • Additional Treatment: You can continue using your usual topical treatments for AD. If your symptoms worsen, additional topical or oral treatments may be provided.

    • Study Duration: At least 36 weeks.

    • Cost & Compensation: Study-related medical care, including examinations and rescue medications (if needed), will be provided at no cost. You may also be eligible for compensation for time and travel, where permitted.

    • Close Medical Monitoring: A dermatologist will closely monitor your condition throughout the study.

    This study may offer a new treatment option for those who haven't found relief with standard therapies.

  • You may be eligible if you:

    • Are at least 12 years old and above

    • Are diagnosed with moderate to severe Atopic Dermatitis for 1 year or more

    • Have a documented history of not responding well to at least one biologic medication or oral JAK inhibitor for atopic dermatitis before joining the study.

    • Weigh greater than or equal to 40 kg (about 88 lbs)

This clinical research study is for adults with moderate to severe Atopic Dermatitis who are currently using topical corticosteroids but haven’t gotten enough relief from previous biologic treatments or oral JAK inhibitors. If you’re still struggling with symptoms, this study may offer an opportunity to explore a potential new treatment option!

Upon calling, press Option 6 then Option 5 for the Clinical Trials Department

Interested in participating in a clinical trial?

By completing this form, you can request more information about available studies, eligibility requirements, and how to get involved. We're here to provide you with the details you need to make an informed decision about participation.

 FAQs

  • The goal is to improve care for people with your condition. The treatment may help your symptoms, but there are no guarantees. However, you’ll receive high-quality medical care and contribute to medical research.

  • Participation in the trial is at no cost to the patient, with no insurance involvement and no billing. You will be compensated for each visit, including reimbursement for transportation arrangements, for all trials.

  • Your privacy is a priority. Only authorized researchers and healthcare professionals will access your data, which is securely stored and usually de-identified to protect your identity.

  • Some studies require more time and effort than others. We will give you a clear schedule so you can decide if the trial fits your routine.

  • Every clinical trial follows strict safety guidelines, and participants are closely monitored. We will provide you with all known risks and side effects before you decide to join.

  • Each trial has specific criteria based on age, medical history, and previous treatments. If you don’t qualify, we may suggest other studies or treatment options.

  • Your health and safety are our top priorities. If you experience any serious side effects, doctors will take immediate action, and you can leave the study at any time.

  • Each trial is different, but participation may involve taking medication, attending check-ups, and answering health-related questions. We will provide a clear schedule outlining the number of visits and study duration.

  • Some trials allow ongoing treatments, while others have restrictions. You can continue seeing your doctor, and we will coordinate with them to ensure your care is managed properly.